Biotechnology Jobs

• Durham, United States
• US$148,500 – US$336,875 pa
• Director

Drives the development and execution of the analytical network strategy across GSK's global supply chain, defining QC testing network principles and translating them into an operational roadmap. Partners with GSC Quality, MSAT, R&D and governance forums on NPI and commercial supply decisions, with a focus on large molecules, ADCs and oligonucleotides. Establishes KPIs and reporting to track strategy impact and mitigate network risk.

• Waltham, United States
• US$202,125 – US$336,875 pa
• Director

Drives the development and execution of the analytical/QC testing network strategy across GSK's global supply chain, translating approved strategy into operational roadmaps and securing governance endorsement. Partners with Quality, MSAT, R&D and product leads on NPI and commercial supply, benchmarks industry best practice, and builds KPI reporting and risk mitigation for large molecules, ADCs and Oligos.

• Poznan Grunwaldzka
• Hybrid
• £410,250 – £683,750 pa
• Director

Provides medical and scientific leadership in safety evaluation and risk management for oncology assets in clinical development, interpreting safety data, escalating signals and delivering evidence-based benefit-risk recommendations. Leads Safety Review Teams and cross-functional matrix groups, representing Safety to governance committees and regulatory authorities. Hybrid role based in the UK, Belgium, Poland or Italy.

• Belgium-Wavre
• Hybrid
• Director

Provides medical and scientific leadership in pharmacovigilance and risk management for oncology assets in clinical development, interpreting safety data, detecting and escalating signals, and delivering evidence-based benefit-risk recommendations. Represents Safety on cross-functional clinical matrix teams and Safety Review Teams, and presents to senior governance committees and regulators. Hybrid role based in the UK, Belgium, Poland or Italy.

• Siena, Italy
• Hybrid
• £81,750 – £136,250 pa
• Director

Provides medical and scientific leadership for pharmacovigilance and risk management of oncology assets in clinical development, interpreting safety data, detecting and escalating signals, and delivering evidence-based benefit-risk recommendations. Represents Safety on cross-functional clinical matrix teams and governance committees, and may lead Safety Review Teams. The role is hybrid across the UK, Belgium, Poland or Italy, with on-site attendance for key meetings.

• USA - Pennsylvania - Upper Providence
• Hybrid · 2 days in office
• US$266,250 – US$443,750 pa
• Director · manages people

Strategically leads global development of an oncology medicine from clinical Proof of Concept to approval in first major markets, acting as single point of accountability. Builds and leads a matrixed Medicine Development Team spanning clinical, medical, commercial and manufacturing, driving evidence packages, governance decisions and lifecycle plans.

• London
• Hybrid
• Director

Provides medical and scientific leadership for pharmacovigilance and risk management of oncology assets in clinical development, interpreting safety data, detecting signals and delivering benefit-risk recommendations. Represents Safety on cross-functional matrix teams and governance committees, and interacts with regulators. Hybrid UK-based role with mentoring and process-improvement duties.

• Belgium-Wavre
• Hybrid
• Director

Provides medical and scientific leadership for pharmacovigilance and risk management of oncology assets in clinical development, interpreting safety data, detecting signals and delivering benefit-risk recommendations. Represents Safety on cross-functional clinical matrix teams and governance committees, and may lead Safety Review Teams. Hybrid role based in the UK with global regulatory and partner interaction.

• Stevenage
• Hybrid · 2 days in office
• US$242,250 – US$403,750 pa
• Director

Accountable for end-to-end clinical development of a multi-tumor oncology asset, from first-in-human through registrational trials, regulatory approval and initial market launch. Acts as senior clinical representative at governance forums and leads cross-functional, matrixed teams spanning research, precision medicine, medical affairs and commercial. Requires deep antibody-drug conjugate and global health authority experience.

AI/ML

• Waltham, United States
• Hybrid · 2 days in office
• US$242,250 – US$403,750 pa
• Director · manages people

Accountable for end-to-end clinical development strategy for a multi-tumor oncology asset, spanning first-in-human through registrational trials, regulatory approval and initial launch. Acts as senior clinical representative at governance forums and leads cross-functional collaboration across research, precision medicine, medical affairs and commercial in a global matrix.

AI/ML

• Zug, Switzerland
• Hybrid · 2 days in office
• US$242,250 – US$403,750 pa
• Director · manages people

Accountable for end-to-end clinical development of a multi-tumor oncology asset, from first-in-human through registrational trials, regulatory approval and launch. Leads cross-functional strategy with research, precision medicine, medical affairs and commercial partners, and represents the program at senior governance forums. Requires deep antibody-drug conjugate and global regulatory experience.

• London
• Hybrid · 2 days in office
• US$242,250 – US$403,750 pa
• Director · manages people

Accountable for end-to-end clinical development strategy for a multi-tumor oncology asset, spanning first-in-human through registrational trials, regulatory filing and initial market launch. Acts as senior clinical representative at governance forums and leads cross-functional, matrixed teams across research, precision medicine, medical affairs and commercial. Requires deep antibody-drug conjugate and global health authority experience.

• USA - Pennsylvania - Upper Providence
• Hybrid · 2 days in office
• US$242,250 – US$403,750 pa
• Director · manages people

Accountable for end-to-end clinical development strategy for an antibody-drug conjugate asset across multiple tumour types, from first-in-human through registrational trials and launch. Acts as senior clinical representative at governance forums and leads cross-functional, matrixed teams spanning research, precision medicine, medical affairs and commercial.

• Stevenage
• Director

Accountable for GSK R&D's enterprise portfolio of external scientific content and data licenses, managing budget, forecasting, cost controls and vendor commercial terms. Acts as senior interface to information providers and connector across scientific, procurement, legal, copyright and technology teams, ensuring copyright-compliant use and positioning content for AI and text-mining exploitation.

Excel · PowerPoint · Word +2

• USA - Pennsylvania - Upper Providence
• Director

Accountable for GSK R&D's enterprise portfolio of external scientific content and data licenses, including budget, forecasting, cost controls and retiring under-used sources. Manages vendor relationships and commercial terms, maintains copyright-compliant governance and user guidance, and works across scientific, procurement, legal, digital and technology teams to make licensed content AI- and text-mining-ready.

Excel · PowerPoint · Word +2